Managing symptoms of rheumatoid arthritis may require trying different medicines to see what works best for you and your symptoms. The approval of Xeljanz has led to changes in how rheumatoid ...

More than 80% of patients with newly diagnosed rheumatoid arthritis, who were using bridging therapy, successfully tapered ...

Preclinical rheumatoid arthritis (RA), also known as pre-rheumatoid arthritis (pre-RA), represents the phase of rheumatoid arthritis (RA) development before symptoms appear, i.e., before inflammatory ...

Rheumatoid arthritis care faces challenges like workforce shortages and delays in diagnosis and treatment initiation. Effective interventions include using technology, streamlining care processes, and ...

Rheumatoid arthritis affects millions of Americans, gradually changing lives as it progresses from subtle joint discomfort to potentially severe mobility limitations. For those living with this ...

Rheumatoid arthritis, also known as RA, affects an estimated 1.3 million people in the United States. Beyond this staggering statistic lies a complex reality: each person's experience with RA is ...

As of 2021, about 17.9 million people around the world were living with rheumatoid arthritis, an autoimmune disease causing inflammation, pain, and swelling in the joints. There is also currently no ...